Sulfasalazine (Azulfidine)
1804
relevant articles (253 outcomes,
270 trials/studies)
found for this Drug
Description:
A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
Also Known As:
Azulfidine; Pleon; Salazopyrin; Sulphasalazine; Ucine; Salicylazosulfapyridine; Alphapharm Brand of Sulfasalazine; Ashbourne Brand of Sulfasalazine; Asulfidine; Azulfadine; Azulfidine EN-tabs; Colo-Pleon; FNA Brand of Sulfasalazine; Henning Berlin Brand of Sulfasalazine; Heyl Brand of Sulfasalazine; Pharmacia Brand 1 of Sulfasalazine; Pharmacia Brand 2 of Sulfasalazine; Pyralin EN; Ratiopharm Brand of Sulfasalazine; Salazosulfapyridine; Sanofi Synthelabo Brand of Sulfasalazine; Sulfasalazin medac; Sulfasalazin-Heyl; Sulfasalazine FNA; Ulcol; medac Brand of Sulfasalazine; ratio-Sulfasalazine; Azulfidine EN tabs; Colo Pleon; Sulfasalazin Heyl; ratio Sulfasalazine; Benzoic acid, 2-hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)-
Relationship Network
Drug Context: Research Results
Experts
Related Diseases
Related Drugs and Biologics
Related Therapies and Procedures